Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-21

Clinical Trial Update: PRECISE: A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor [NA]

View source ↗

Summary

A completed prospective, multi-center evaluation of the accuracy of a novel implanted continuous glucose sensor in individuals with diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eversense Continuous Glucose Monitoring System

Snippet

Sponsor: Senseonics, Inc. | Conditions: Diabetes Mellitus | NA | Status: COMPLETED